Skip to main content

Conmed Value Stock - Dividend - Research Selection

Conmed

ISIN: US2074101013 , WKN: 886793

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and uterine manipulator (VCARE) for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers general surgery product in the areas of endoscopic technologies, including minimally invasive diagnostic and therapeutic products; critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician\'s office electrosurgical product used by dermatologists. The company\'s products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Here's Why Conmed (CNMD) is a Strong Value Stock

2025-09-17
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

CONMED's (NYSE:CNMD) Dividend Will Be $0.20

2025-09-12
The board of CONMED Corporation ( NYSE:CNMD ) has announced that it will pay a dividend on the 3rd of October, with...

CONMED (NYSE:CNMD) Could Be A Buy For Its Upcoming Dividend

2025-09-11
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see CONMED...

2 Reasons CNMD is Risky and 1 Stock to Buy Instead

2025-09-11
Over the past six months, CONMED’s stock price fell to $52.81. Shareholders have lost 14.7% of their capital, which is disappointing considering the S&P 500 has climbed by 17.4%. This may have investors wondering how to approach the situation.

CONMED Corporation Adds Kim Kelderman to its Board of Directors

2025-09-09
LARGO, Fla., September 09, 2025--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025.

1 Profitable Stock for Long-Term Investors and 2 We Brush Off

2025-09-09
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

2025-09-08
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Conmed Constrained By Execution, Tariffs, And Sector Sentiment

2025-09-05
Conmed's share price has underperformed despite resilient fundamentals. Click here to check out my analysis of CNMD stock.

Is CONMED Corporation (NYSE:CNMD) Trading At A 37% Discount?

2025-09-01
Key Insights Using the 2 Stage Free Cash Flow to Equity, CONMED fair value estimate is US$86.29 CONMED is estimated to...

Here's Why Conmed (CNMD) is a Strong Momentum Stock

2025-08-28
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.